NEWLAND PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.45 CNY | -1.40% |
|
-6.93% | +3.94% |
| Sales 2022 | 627M 86.65M 6.82B | Sales 2023 | 651M 89.97M 7.08B | Capitalization | 4.16B 575M 45.24B |
|---|---|---|---|---|---|
| Net income 2022 | 132M 18.23M 1.43B | Net income 2023 | 159M 21.96M 1.73B | EV / Sales 2022 | 4.95 x |
| Net cash position 2022 | 747M 103M 8.12B | Net cash position 2023 | 857M 118M 9.31B | EV / Sales 2023 | 5.07 x |
| P/E ratio 2022 |
22.4
x | P/E ratio 2023 |
26.3
x | Employees | 1,010 |
| Yield 2022 |
1.73% | Yield 2023 |
1.92% | Free-Float | 21.38% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.40% | ||
| 1 week | -6.93% | ||
| Current month | +8.80% | ||
| 1 month | +27.84% | ||
| 3 months | +35.53% | ||
| 6 months | -7.52% | ||
| Current year | +3.94% |
1 week
14.79
16.39
1 month
11.6518.38
Current year
9.3018.38
1 year
9.3022.49
3 years
9.3024.76
5 years
9.3024.76
10 years
9.3024.76
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/05/24 | 15.45 | -1.40% | 11,202,530 |
| 21/05/24 | 15.67 | -4.28% | 14,314,680 |
| 20/05/24 | 16.37 | +8.12% | 23,720,120 |
| 17/05/24 | 15.14 | -2.20% | 16,326,150 |
| 16/05/24 | 15.48 | -2.64% | 17,121,760 |
End-of-day quote Shenzhen S.E., May 21, 2024
More quotes
Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.94% | 607M | |
| +37.74% | 723B | |
| +32.22% | 598B | |
| -2.07% | 364B | |
| +20.25% | 331B | |
| +2.99% | 288B | |
| +16.60% | 244B | |
| +9.77% | 210B | |
| -5.15% | 208B | |
| +7.43% | 169B |
- Stock Market
- Equities
- 301277 Stock
